KEGG   PATHWAY: tup04934
Entry
tup04934                    Pathway                                
Name
Cushing syndrome - Tupaia chinensis (Chinese tree shrew)
Description
Cushing syndrome (CS) is a rare disorder resulting from prolonged exposure to excess glucocorticoids via exogenous and endogenous sources. The typical clinical features of CS are related to hypercortisolism and include accumulation of central fat, moon facies, neuromuscular weakness, osteoporosis or bone fractures, metabolic complications, and mood changes. Traditionally, endogenous CS is classified as adrenocorticotropic hormone (ACTH)-dependent (about 80%) or ACTH- independent (about 20%). Among ACTH-dependent forms, pituitary corticotroph adenoma (Cushing's disease) is most common. Most pituitary tumors are sporadic, resulting from monoclonal expansion of a single mutated cell. Recently recurrent activating somatic driver mutations in the ubiquitin-specific protease 8 gene (USP8) were identified in almost half of corticotroph adenoma. Germline mutations in MEN1 (encoding menin), AIP (encoding aryl-hydrocarbon receptor-interacting protein), PRKAR1A (encoding cAMP-dependent protein kinase type I alpha regulatory subunit) and CDKN1B (encoding cyclin-dependent kinase inhibitor 1B; also known as p27 Kip1) have been identified in familial forms of pituitary adenomas. However, the frequency of familial pituitary adenomas is less than 5% in patients with pituitary adenomas. Among ACTH-independent CS, adrenal adenoma is most common. Rare adrenal causes of CS include primary bilateral macronodular adrenal hyperplasia (BMAH) or primary pigmented nodular adrenocortical disease (PPNAD).
Class
Human Diseases; Endocrine and metabolic disease
Pathway map
tup04934  Cushing syndrome
tup04934

Organism
Tupaia chinensis (Chinese tree shrew) [GN:tup]
Gene
102475506  CRH; corticotropin releasing hormone [KO:K05256]
102478239  CRHR1; corticotropin releasing hormone receptor 1 [KO:K04578]
102499284  CRHR2; corticotropin releasing hormone receptor 2 [KO:K04579]
102489563  GNAS; guanine nucleotide-binding protein G(s) subunit alpha isoforms XLas [KO:K04632]
102501321  neuroendocrine secretory protein 55 [KO:K04632]
102468873  ADCY1; adenylate cyclase 1 [KO:K08041] [EC:4.6.1.1]
102492353  ADCY2; adenylate cyclase 2 [KO:K08042] [EC:4.6.1.1]
102477532  ADCY3; adenylate cyclase 3 [KO:K08043] [EC:4.6.1.1]
102490273  ADCY4; adenylate cyclase 4 [KO:K08044] [EC:4.6.1.1]
102490639  ADCY5; adenylate cyclase 5 [KO:K08045] [EC:4.6.1.1]
102468478  ADCY6; adenylate cyclase 6 [KO:K08046] [EC:4.6.1.1]
102496578  ADCY7; adenylate cyclase 7 [KO:K08047] [EC:4.6.1.1]
102472317  ADCY8; adenylate cyclase 8 [KO:K08048] [EC:4.6.1.1]
102477344  ADCY9; adenylate cyclase 9 [KO:K08049] [EC:4.6.1.1]
102502506  PRKACB; protein kinase cAMP-activated catalytic subunit beta [KO:K04345] [EC:2.7.11.11]
102478525  PRKACA; protein kinase cAMP-activated catalytic subunit alpha [KO:K04345] [EC:2.7.11.11]
102500092  CREB1; cAMP responsive element binding protein 1 [KO:K05870]
102473406  ATF2; activating transcription factor 2 [KO:K04450]
102478154  ATF4; activating transcription factor 4 [KO:K04374]
102491362  CREB3L1; cAMP responsive element binding protein 3 like 1 [KO:K09048]
102471928  CREB3L2; cAMP responsive element binding protein 3 like 2 [KO:K09048]
102469074  CREB3; cAMP responsive element binding protein 3 [KO:K09048]
102468245  cyclic AMP-responsive element-binding protein 3-like [KO:K09048]
102494703  CREB3L4; cAMP responsive element binding protein 3 like 4 [KO:K09048]
102484102  CREB3L3; cAMP responsive element binding protein 3 like 3 [KO:K09048]
102487006  CREB5; cAMP responsive element binding protein 5 [KO:K09047]
102484080  ATF6B; activating transcription factor 6 beta [KO:K09049]
102475076  MEN1; menin 1 [KO:K14970]
102488704  ASH2L; ASH2 like histone lysine methyltransferase complex subunit [KO:K14964]
102502448  RBBP5; RB binding protein 5, histone lysine methyltransferase complex subunit [KO:K14961]
102475039  WDR5B; WD repeat domain 5B [KO:K14963]
102501799  WDR5; WD repeat domain 5 [KO:K14963]
102473382  KMT2A; lysine methyltransferase 2A [KO:K09186] [EC:2.1.1.354]
102480722  KMT2D; lysine methyltransferase 2D [KO:K09187] [EC:2.1.1.354]
102484147  CDKN2C; cyclin dependent kinase inhibitor 2C [KO:K06622]
102500294  CDKN2B; cyclin dependent kinase inhibitor 2B [KO:K04685]
102495801  cyclin-dependent kinase 4 inhibitor B [KO:K04685]
102493291  CDK4; cyclin dependent kinase 4 [KO:K02089] [EC:2.7.11.22]
102488432  CDK6; cyclin dependent kinase 6 [KO:K02091] [EC:2.7.11.22]
102490651  CCND1; cyclin D1 [KO:K04503]
102499507  RB1; RB transcriptional corepressor 1 [KO:K06618]
102484832  E2F1; E2F transcription factor 1 [KO:K17454]
102479669  E2F2; E2F transcription factor 2 [KO:K09389]
102499416  E2F3; E2F transcription factor 3 [KO:K06620]
102468129  RASD1; ras related dexamethasone induced 1 [KO:K07843]
102476737  GNAI3; G protein subunit alpha i3 [KO:K04630]
102479323  GNAI1; G protein subunit alpha i1 [KO:K04630]
102475420  GNAI2; G protein subunit alpha i2 [KO:K04630]
102492803  AHR; aryl hydrocarbon receptor [KO:K09093]
102471309  AIP; aryl hydrocarbon receptor interacting protein [KO:K17767]
102482649  AIPL1; aryl hydrocarbon receptor interacting protein like 1 [KO:K17767]
102503401  ARNT; aryl hydrocarbon receptor nuclear translocator [KO:K09097]
102501235  CDKN1B; cyclin dependent kinase inhibitor 1B [KO:K06624]
102500015  CDK2; cyclin dependent kinase 2 [KO:K02206] [EC:2.7.11.22]
102492088  CCNE2; cyclin E2 [KO:K06626]
102468317  CCNE1; cyclin E1 [KO:K06626]
102490159  CDKN1A; cyclin dependent kinase inhibitor 1A [KO:K06625]
102484770  CACNA1D; calcium voltage-gated channel subunit alpha1 D [KO:K04851]
102482779  CACNA1F; calcium voltage-gated channel subunit alpha1 F [KO:K04853]
102481015  CACNA1S; calcium voltage-gated channel subunit alpha1 S [KO:K04857]
102494625  CAMK2A; calcium/calmodulin dependent protein kinase II alpha [KO:K04515] [EC:2.7.11.17]
102482912  CAMK2D; calcium/calmodulin dependent protein kinase II delta [KO:K04515] [EC:2.7.11.17]
102472689  CAMK2B; calcium/calmodulin dependent protein kinase II beta [KO:K04515] [EC:2.7.11.17]
102503259  CAMK2G; calcium/calmodulin dependent protein kinase II gamma [KO:K04515] [EC:2.7.11.17]
102475072  RAP1A; RAP1A, member of RAS oncogene family [KO:K04353]
102472381  RAP1B; RAP1B, member of RAS oncogene family [KO:K07836]
102477389  BRAF; B-Raf proto-oncogene, serine/threonine kinase [KO:K04365] [EC:2.7.11.1]
102476496  MAP2K1; mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
102483700  MAP2K2; mitogen-activated protein kinase kinase 2 [KO:K04369] [EC:2.7.12.2]
102496453  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
102483057  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
102490723  NR4A1; nuclear receptor subfamily 4 group A member 1 [KO:K04465]
102485304  EGFR; epidermal growth factor receptor [KO:K04361] [EC:2.7.10.1]
102470437  USP8; ubiquitin specific peptidase 8 [KO:K11839] [EC:3.4.19.12]
102498583  POMC; proopiomelanocortin [KO:K05228]
102491977  MC2R; melanocortin 2 receptor [KO:K04200]
102473291  MRAP; melanocortin 2 receptor accessory protein [KO:K22398]
102472054  PDE8B; phosphodiesterase 8B [KO:K18437] [EC:3.1.4.53]
102475658  PDE8A; phosphodiesterase 8A [KO:K18437] [EC:3.1.4.53]
102474100  PDE11A; phosphodiesterase 11A [KO:K13298] [EC:3.1.4.17 3.1.4.35]
102492895  NR5A1; nuclear receptor subfamily 5 group A member 1 [KO:K08560]
102473003  SP1; Sp1 transcription factor [KO:K04684]
102476678  PBX1; PBX homeobox 1 [KO:K09355]
102492986  cytochrome P450 11B1, mitochondrial [KO:K00497] [EC:1.14.15.4]
102471986  cytochrome P450 11B2, mitochondrial [KO:K00497] [EC:1.14.15.4]
102472543  steroid 17-alpha-hydroxylase/17,20 lyase [KO:K00512] [EC:1.14.14.19 1.14.14.32]
102488286  STAR; steroidogenic acute regulatory protein [KO:K16931]
102493014  NCEH1; neutral cholesterol ester hydrolase 1 [KO:K14349] [EC:3.1.1.-]
102481936  ARMC5; armadillo repeat containing 5 [KO:K22499]
102471092  AGT; angiotensinogen [KO:K09821]
102469571  AGTR1; angiotensin II receptor type 1 [KO:K04166]
102468263  GNAQ; G protein subunit alpha q [KO:K04634]
102479071  GNA11; G protein subunit alpha 11 [KO:K04635]
102477438  PLCB1; phospholipase C beta 1 [KO:K05858] [EC:3.1.4.11]
102476196  PLCB4; phospholipase C beta 4 [KO:K05858] [EC:3.1.4.11]
102472532  PLCB3; phospholipase C beta 3 [KO:K05858] [EC:3.1.4.11]
102492903  PLCB2; phospholipase C beta 2 [KO:K05858] [EC:3.1.4.11]
102473622  ITPR1; inositol 1,4,5-trisphosphate receptor type 1 [KO:K04958]
102482868  ITPR2; inositol 1,4,5-trisphosphate receptor type 2 [KO:K04959]
102475587  ITPR3; inositol 1,4,5-trisphosphate receptor type 3 [KO:K04960]
102488856  KCNK2; potassium two pore domain channel subfamily K member 2 [KO:K04913]
102486198  CACNA1G; calcium voltage-gated channel subunit alpha1 G [KO:K04854]
102497538  CACNA1I; calcium voltage-gated channel subunit alpha1 I [KO:K04856]
102475070  ORAI1; ORAI calcium release-activated calcium modulator 1 [KO:K16056]
102493706  KCNA4; potassium voltage-gated channel subfamily A member 4 [KO:K04877]
102470255  KCNK3; potassium two pore domain channel subfamily K member 3 [KO:K04914]
102484417  LDLR; low density lipoprotein receptor [KO:K12473]
102502354  SCARB1; scavenger receptor class B member 1 [KO:K13885]
102487565  cholesterol side-chain cleavage enzyme, mitochondrial-like [KO:K00498] [EC:1.14.15.6]
102470981  3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase-like [KO:K00070] [EC:1.1.1.145 5.3.3.1]
102491327  steroid 21-hydroxylase [KO:K00513] [EC:1.14.14.16]
102479916  FH; fumarate hydratase [KO:K01679] [EC:4.2.1.2]
102499190  WNT1; Wnt family member 1 [KO:K03209]
102479831  WNT2B; Wnt family member 2B [KO:K00182]
102483867  WNT2; Wnt family member 2 [KO:K00182]
102501628  WNT3A; Wnt family member 3A [KO:K00312]
102489001  WNT3; Wnt family member 3 [KO:K00312]
102493340  WNT4; Wnt family member 4 [KO:K00408]
102489573  WNT5A; Wnt family member 5A [KO:K00444]
102467720  WNT5B; Wnt family member 5B [KO:K00444]
102483667  WNT6; Wnt family member 6 [KO:K00445]
102484353  WNT7A; Wnt family member 7A [KO:K00572]
102500004  WNT7B; Wnt family member 7B [KO:K00572]
102468229  WNT8B; Wnt family member 8B [KO:K00714]
102490209  WNT8A; Wnt family member 8A [KO:K00714]
102496226  WNT9A; Wnt family member 9A [KO:K01064]
102489417  WNT9B; Wnt family member 9B [KO:K01064]
102481567  WNT10B; Wnt family member 10B [KO:K01357]
102483253  WNT10A; Wnt family member 10A [KO:K01357]
102494826  WNT11; Wnt family member 11 [KO:K01384]
102497530  WNT16; Wnt family member 16 [KO:K01558]
102492163  FZD7; frizzled class receptor 7 [KO:K02432]
102499195  FZD1; frizzled class receptor 1 [KO:K02432]
102479307  FZD2; frizzled class receptor 2 [KO:K02235]
102474963  FZD3; frizzled class receptor 3 [KO:K02329]
102491949  FZD4; frizzled class receptor 4 [KO:K02354]
102475157  FZD5; frizzled class receptor 5 [KO:K02375]
102487480  FZD8; frizzled class receptor 8 [KO:K02375]
102492375  FZD6; frizzled class receptor 6 [KO:K02376]
102479813  FZD10; frizzled class receptor 10 [KO:K02842]
102481011  FZD9; frizzled class receptor 9 [KO:K02842]
102485749  DVL2; dishevelled segment polarity protein 2 [KO:K02353]
102472352  DVL3; dishevelled segment polarity protein 3 [KO:K02353]
102468994  DVL1; dishevelled segment polarity protein 1 [KO:K02353]
102476038  GSK3B; glycogen synthase kinase 3 beta [KO:K03083] [EC:2.7.11.26]
102469399  AXIN1; axin 1 [KO:K02157]
102493766  AXIN2; axin 2 [KO:K04385]
102472740  CTNNB1; catenin beta 1 [KO:K02105]
102484859  APC; APC, WNT signaling pathway regulator [KO:K02085]
102470052  APC2; APC2, WNT signaling pathway regulator [KO:K02085]
102484318  TCF7; transcription factor 7 (T-cell specific, HMG-box) [KO:K02620]
102481394  TCF7L1; transcription factor 7 like 1 [KO:K04490]
102472810  TCF7L2; transcription factor 7 like 2 [KO:K04491]
102474621  LEF1; lymphoid enhancer binding factor 1 [KO:K04492]
Compound
C00020  AMP
C00076  Calcium cation
C00187  Cholesterol
C00238  Potassium cation
C00410  Progesterone
C00575  3',5'-Cyclic AMP
C00735  Cortisol
C01176  17alpha-Hydroxyprogesterone
C01245  D-myo-Inositol 1,4,5-trisphosphate
C01953  Pregnenolone
C05138  17alpha-Hydroxypregnenolone
C05488  11-Deoxycortisol
C07557  2,3,7,8-Tetrachlorodibenzodioxin
Reference
  Authors
Lacroix A, Feelders RA, Stratakis CA, Nieman LK
  Title
Cushing's syndrome.
  Journal
Lancet 386:913-27 (2015)
DOI:10.1016/S0140-6736(14)61375-1
Reference
  Authors
Xiong Q, Ge W
  Title
Gene mutations in Cushing's disease.
  Journal
Biomed Rep 5:277-282 (2016)
DOI:10.3892/br.2016.729
Reference
  Authors
Fukuoka H, Takahashi Y
  Title
The role of genetic and epigenetic changes in pituitary tumorigenesis.
  Journal
Neurol Med Chir (Tokyo) 54 Suppl 3:943-57 (2014)
DOI:10.2176/nmc.suppl.2014-3
Reference
  Authors
Quereda V, Malumbres M
  Title
Cell cycle control of pituitary development and disease.
  Journal
J Mol Endocrinol 42:75-86 (2009)
DOI:10.1677/JME-08-0146
Reference
  Authors
Caimari F, Korbonits M
  Title
Novel Genetic Causes of Pituitary Adenomas.
  Journal
Clin Cancer Res 22:5030-5042 (2016)
DOI:10.1158/1078-0432.CCR-16-0452
Reference
  Authors
Lecoq AL, Kamenicky P, Guiochon-Mantel A, Chanson P
  Title
Genetic mutations in sporadic pituitary adenomas--what to screen for?
  Journal
Nat Rev Endocrinol 11:43-54 (2015)
DOI:10.1038/nrendo.2014.181
Reference
  Authors
Hannah-Shmouni F, Faucz FR, Stratakis CA
  Title
Alterations of Phosphodiesterases in Adrenocortical Tumors.
  Journal
Front Endocrinol (Lausanne) 7:111 (2016)
DOI:10.3389/fendo.2016.00111
Reference
  Authors
Melmed S
  Title
Pathogenesis of pituitary tumors.
  Journal
Nat Rev Endocrinol 7:257-66 (2011)
DOI:10.1038/nrendo.2011.40
Reference
  Authors
Daly AF, Tichomirowa MA, Beckers A
  Title
Genetic, molecular and clinical features of familial isolated pituitary adenomas.
  Journal
Horm Res 71 Suppl 2:116-22 (2009)
DOI:10.1159/000192448
Reference
  Authors
Albani A, Theodoropoulou M, Reincke M
  Title
Genetics of Cushing's disease.
  Journal
Clin Endocrinol (Oxf) 88:3-12 (2018)
DOI:10.1111/cen.13457
Reference
  Authors
Duan K, Hernandez KG, Mete O
  Title
Clinicopathological correlates of adrenal Cushing's syndrome.
  Journal
Postgrad Med J 91:331-42 (2015)
DOI:10.1136/postgradmedj-2014-202612rep
Reference
  Authors
Drougat L, Espiard S, Bertherat J
  Title
Genetics of primary bilateral macronodular adrenal hyperplasia: a model for early diagnosis of Cushing's syndrome?
  Journal
Eur J Endocrinol 173:M121-31 (2015)
DOI:10.1530/EJE-15-0532
Reference
  Authors
Stratakis CA, Boikos SA
  Title
Genetics of adrenal tumors associated with Cushing's syndrome: a new classification for bilateral adrenocortical hyperplasias.
  Journal
Nat Clin Pract Endocrinol Metab 3:748-57 (2007)
DOI:10.1038/ncpendmet0648
Reference
  Authors
Refojo D, Holsboer F
  Title
CRH signaling. Molecular specificity for drug targeting in the CNS.
  Journal
Ann N Y Acad Sci 1179:106-19 (2009)
DOI:10.1111/j.1749-6632.2009.04983.x
Reference
  Authors
Kovalovsky D, Refojo D, Liberman AC, Hochbaum D, Pereda MP, Coso OA, Stalla GK, Holsboer F, Arzt E
  Title
Activation and induction of NUR77/NURR1 in corticotrophs by CRH/cAMP: involvement of calcium, protein kinase A, and MAPK pathways.
  Journal
Mol Endocrinol 16:1638-51 (2002)
DOI:10.1210/mend.16.7.0863
Reference
  Authors
Lacroix A, Baldacchino V, Bourdeau I, Hamet P, Tremblay J
  Title
Cushing's syndrome variants secondary to aberrant hormone receptors.
  Journal
Trends Endocrinol Metab 15:375-82 (2004)
DOI:10.1016/j.tem.2004.08.007
Reference
  Authors
Reincke M, Sbiera S, Hayakawa A, Theodoropoulou M, Osswald A, Beuschlein F, Meitinger T, Mizuno-Yamasaki E, Kawaguchi K, Saeki Y, Tanaka K, Wieland T, Graf E, Saeger W, Ronchi CL, Allolio B, Buchfelder M, Strom TM, Fassnacht M, Komada M
  Title
Mutations in the deubiquitinase gene USP8 cause Cushing's disease.
  Journal
Nat Genet 47:31-8 (2015)
DOI:10.1038/ng.3166
Reference
  Authors
Kaiser UB
  Title
Cushing's disease: towards precision medicine.
  Journal
Cell Res 25:649-50 (2015)
DOI:10.1038/cr.2015.53
Reference
  Authors
Uzilov AV, Cheesman KC, Fink MY, Newman LC, Pandya C, Lalazar Y, Hefti M, Fowkes M, Deikus G, Lau CY, Moe AS, Kinoshita Y, Kasai Y, Zweig M, Gupta A, Starcevic D, Mahajan M, Schadt EE, Post KD, Donovan MJ, Sebra R, Chen R, Geer EB
  Title
Identification of a novel RASD1 somatic mutation in a USP8-mutated corticotroph adenoma.
  Journal
Cold Spring Harb Mol Case Stud 3:a001602 (2017)
DOI:10.1101/mcs.a001602
Reference
  Authors
Huang C, Shi Y, Zhao Y
  Title
USP8 mutation in Cushing's disease.
  Journal
Oncotarget 6:18240-1 (2015)
DOI:10.18632/oncotarget.4856
Reference
  Authors
Theodoropoulou M, Reincke M, Fassnacht M, Komada M
  Title
Decoding the genetic basis of Cushing's disease: USP8 in the spotlight.
  Journal
Eur J Endocrinol 173:M73-83 (2015)
DOI:10.1530/EJE-15-0320
Reference
  Authors
Yu L, Zhang J, Guo X, Chen X, He Z, He Q
  Title
ARMC5 mutations in familial and sporadic primary bilateral macronodular adrenal hyperplasia.
  Journal
PLoS One 13:e0191602 (2018)
DOI:10.1371/journal.pone.0191602
Reference
  Authors
Wu X, Hua X
  Title
Menin, histone h3 methyltransferases, and regulation of cell proliferation: current knowledge and perspective.
  Journal
Curr Mol Med 8:805-15 (2008)
DOI:10.2174/156652408786733702
Reference
  Authors
Ozfirat Z, Korbonits M
  Title
AIP gene and familial isolated pituitary adenomas.
  Journal
Mol Cell Endocrinol 326:71-9 (2010)
DOI:10.1016/j.mce.2010.05.001
Related
pathway
tup00020  Citrate cycle (TCA cycle)
tup00140  Steroid hormone biosynthesis
tup04020  Calcium signaling pathway
tup04024  cAMP signaling pathway
tup04110  Cell cycle
tup04310  Wnt signaling pathway
tup04927  Cortisol synthesis and secretion
tup04960  Aldosterone-regulated sodium reabsorption
KO pathway
ko04934   
LinkDB

DBGET integrated database retrieval system